هدف از اين مطالعه بررسي تاثير يك داروي گياهي روي عوارض ريوي دربيماران مبتلا به كويد19 مي باشد.
مواد و روش ها:
40 بيمار مبتلا به بيماري كوويد-19 با سن بالاتر از 18 سال و ميانگين سني بالاتر از 55 سال با نسبت 60 درصد مردها به زن ها كه علايمي نظير تب بالاي 38 درجه، شمارش لنفوسيت كم تر از 1200، CRP مثبت، علايم تنفسي و درگيري ريوي در گرافي ريه با سي تي اسكن را داشتند، بعد از تكميل فرم رضايت نامه براي شركت در مطالعه انتخاب و به دو گروه مداخله و شاهد طبقه بندي شدند. گروه شاهد تحت درمان با قرص كلترا 400 ميلي گرمي و قرص هيدروكسي كلروكين 200 ميلي گرمي هر 12 ساعت قرار گرفت و گروه مداخله علاوه بر كلترا و هيدروكسي كلركين، 5 ميلي ليتر داروي گياهي 3 بار در روز دريافت كردند. آناليز آماري با برنامه SPSS و آزمون مربع كاي و t-test انجام شد.
يافته ها:
ﯾﺎﻓﺘﻪﻫﺎ: ﮔﺮوه ﻣﺪاﺧﻠﻪ اﻓﺰاﯾﺶ ﺳﺮﻋﺖ ﺑﻬﺒﻮدي و ﮐﺎﻫﺶ ﻣﯿﺎﻧﮕﯿﻦ زﻣﺎن ﺑﺴﺘﺮي ﺑﻮدن ﺑﯿﻤﺎران ﻧﺴﺒﺖ ﺑﻪ ﮔﺮوه ﺷــﺎﻫﺪ را ﺑــﻪ ﺻﻮرت ﻣﻌﻨﯽداري از 8/5 روز ﺑﻪ 5 روز، ﻧﺸﺎن داد. ﺗﻔﺎوت ﺗﻐﯿﯿﺮات CRP در دو ﮔﺮوه ﺷﺎﻫﺪ و آزﻣﻮن از ﻧﻈﺮ آﻣﺎري ﻣﻌﻨﯽدار ﺑﻮد)0/05
چكيده لاتين :
This research aimed at investigating the effect of herbal medicine on
reduction of pulmonary complications in patients with Coronavirus disease 2019 (COVID-19).
Materials and methods: Forty patients with COVID-19 infection older than 18 years of age
(60% men) with the average age of over 55 years old enrolled in this study. Written consent was obtained
and participants with the following symptoms were divided into experimental group and control group: body
temperature higher than 38℃, lymphocyte counts of less than 1200, positive CRP, respiratory symptoms,
and pulmonary involvement in lung CT scan. The control group was treated with 400 mg Kaletra® and
200 mg hydroxychloroquine oral every 12 hours, and the experimental group, in addition to this regimen, received 5
ml of a herbal medicine (consisting of Satureja hortensis L., Hypericum perforatum L. and Foeniculum
vulgare L.) three times a day. Statistical analysis was done in SPSS applying Chi-square test and t-test.
Results: The herbal medicine was found to be significantly effective in decreasing the time of
hospitalization and recovery from the disease (8.5 days in control group vs. 5 days in experimental group,
(P<0.05). Also, CRP levels decreased significantly in experimental group and CRP level changes in the
control group were 4.75 times higher than the experimental group (P<0.05). Furthermore, pulmonary
involvement improved by 8.34% in experimental group compared to the control group (P<0.05).
Conclusion: The herbal drug administered in this study, considerably improved lung symptoms
and decreased the course of treatment of COVID-19 infection.